Bernard J. Cassidy - Mar 6, 2025 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & General Counsel
Signature
/s/ Bernard J. Cassidy
Stock symbol
SANA
Transactions as of
Mar 6, 2025
Transactions value $
-$7,252
Form type
4
Date filed
3/10/2025, 08:12 PM
Previous filing
Mar 8, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Options Exercise $0 +11K +10.54% $0.00 116K Mar 7, 2025 Direct F1
transaction SANA Common Stock Tax liability -$7.25K -2.83K -2.45% $2.56 113K Mar 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Restricted Stock Units Award $0 +53.3K $0.00 53.3K Mar 6, 2025 Common Stock 53.3K Direct F2, F3
transaction SANA Stock Option (Right to Buy) Award $0 +240K $0.00 240K Mar 6, 2025 Common Stock 240K $2.55 Direct F4
transaction SANA Restricted Stock Units Options Exercise $0 -11K -25% $0.00 33.1K Mar 7, 2025 Common Stock 11K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,001 shares acquired on May 15, 2023 and 3,000 shares acquired on each of November 15, 2023, May 15, 2024 and November 15, 2024, in each case, pursuant to Sana Biotechnology, Inc.'s ("Sana") 2021 Employee Stock Purchase Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of Sana common stock.
F3 The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F4 The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F5 The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.